Avalglucosidase Alfa
CAS nullBiologic
Overview
Avalglucosidase alfa is a recombinant human enzyme used for treating Pompe disease, a genetic disorder characterized by the buildup of glycogen in the body's cells. It works by replacing the deficient enzyme acid alpha-glucosidase (GAA) in affected patients, helping to reduce glycogen accumulation.
Therapeutic areas
Genetic DisordersMetabolic Disorders
Verified Supplier Partner
Do you supply Avalglucosidase Alfa? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.